• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Multiparametric CT for Noninvasive Staging of Hepatitis C Virus-Related Liver Fibrosis: Correlation With the Histopathologic Fibrosis Score.多参数 CT 对丙型肝炎病毒相关肝纤维化的无创分期:与组织病理学纤维化评分的相关性。
AJR Am J Roentgenol. 2019 Mar;212(3):547-553. doi: 10.2214/AJR.18.20284. Epub 2019 Jan 15.
2
Multiinstitutional Evaluation of the Liver Surface Nodularity Score on CT for Staging Liver Fibrosis and Predicting Liver-Related Events in Patients With Hepatitis C.多机构对CT肝脏表面结节评分在丙型肝炎患者肝纤维化分期及预测肝脏相关事件中的评估
AJR Am J Roentgenol. 2022 May;218(5):833-845. doi: 10.2214/AJR.21.27062. Epub 2021 Dec 22.
3
Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus.MDCT 对丙型肝炎病毒患者肝纤维化分期的肝表面结节量化的准确性。
Abdom Radiol (NY). 2018 Nov;43(11):2980-2986. doi: 10.1007/s00261-018-1572-6.
4
Utility of Multiparametric CT for Identification of High-Risk NAFLD.多参数 CT 在识别高危非酒精性脂肪性肝病中的应用。
AJR Am J Roentgenol. 2021 Mar;216(3):659-668. doi: 10.2214/AJR.20.22842. Epub 2021 Jan 21.
5
Staging of Liver Fibrosis by Means of Semiautomatic Measurement of Liver Surface Nodularity in MRI.MRI 半自动测量肝表面结节度对肝纤维化分期的应用。
AJR Am J Roentgenol. 2020 Sep;215(3):624-630. doi: 10.2214/AJR.19.22041. Epub 2020 Jul 1.
6
CT texture analysis of the liver for assessing hepatic fibrosis in patients with hepatitis C virus.CT 纹理分析肝脏评估丙型肝炎病毒患者肝纤维化。
Br J Radiol. 2019 Jan;92(1093):20180153. doi: 10.1259/bjr.20180153. Epub 2018 Oct 11.
7
Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.基于影像学的瞬时弹性成像技术评估慢性乙型肝炎患者的显著纤维化:初步研究。
World J Gastroenterol. 2019 Jul 7;25(25):3256-3267. doi: 10.3748/wjg.v25.i25.3256.
8
Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients.在丙型肝炎单感染及人类免疫缺陷病毒/丙型肝炎合并感染患者中使用实时剪切波弹性成像评估肝纤维化
J Ultrasound Med. 2016 Jun;35(6):1299-308. doi: 10.7863/ultra.15.08066. Epub 2016 May 5.
9
A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: a comparison using histology with internal-external validation.一种非侵入性算法可准确预测丙型肝炎的晚期纤维化:一项使用组织学进行内部-外部验证的比较研究。
J Hepatol. 2008 Oct;49(4):564-71. doi: 10.1016/j.jhep.2008.07.007. Epub 2008 Jul 24.
10
Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis.多层螺旋CT肝脏表面结节量化作为肝纤维化分期无创生物标志物的准确性
AJR Am J Roentgenol. 2016 Dec;207(6):1194-1199. doi: 10.2214/AJR.16.16514. Epub 2016 Aug 30.

引用本文的文献

1
Ultra-low-dose hepatic computed tomography with a novel real-time deep learning-based noise reduction algorithm: a prospective cross-sectional analysis of image quality and lesion detection.采用新型基于深度学习的实时降噪算法的超低剂量肝脏计算机断层扫描:图像质量和病变检测的前瞻性横断面分析
Quant Imaging Med Surg. 2025 Aug 1;15(8):7006-7018. doi: 10.21037/qims-2025-365. Epub 2025 Jul 24.
2
Deep Learning for Computed Tomography Assessment of Hepatic Fibrosis and Cirrhosis: A Systematic Review.深度学习用于肝脏纤维化和肝硬化的计算机断层扫描评估:一项系统综述。
Mayo Clin Proc Digit Health. 2023 Oct 27;1(4):574-585. doi: 10.1016/j.mcpdig.2023.08.008. eCollection 2023 Dec.
3
Navigating Complex Challenges: Preoperative Assessment and Surgical Strategies for Liver Resection in Patients with Fibrosis or Cirrhosis.应对复杂挑战:纤维化或肝硬化患者肝切除术前评估与手术策略
Biomedicines. 2024 Jun 6;12(6):1264. doi: 10.3390/biomedicines12061264.
4
The impact of hepatic and splenic volumetric assessment in imaging for chronic liver disease: a narrative review.肝脏和脾脏容积评估在慢性肝病影像学检查中的影响:一项叙述性综述
Insights Imaging. 2024 Jun 18;15(1):146. doi: 10.1186/s13244-024-01727-3.
5
Post-contrast CT liver attenuation alone is superior to the liver-spleen difference for identifying moderate hepatic steatosis.单纯增强 CT 肝脏衰减值对于诊断中度肝脂肪变优于肝脾 CT 值差异。
Eur Radiol. 2024 Nov;34(11):7041-7052. doi: 10.1007/s00330-024-10816-2. Epub 2024 Jun 4.
6
Assessing Liver Fibrosis Using 2D-SWE Liver Ultrasound Elastography and Dynamic Liver Scintigraphy with 99mTc-mebrofenin: A Comparative Prospective Single-Center Study.使用 2D-SWE 肝脏超声弹性成像和 99mTc-美罗芬酸动态肝脏闪烁显像评估肝纤维化:一项比较前瞻性单中心研究。
Medicina (Kaunas). 2023 Feb 28;59(3):479. doi: 10.3390/medicina59030479.
7
Diagnostic accuracy of ultrasound-based multimodal radiomics modeling for fibrosis detection in chronic kidney disease.基于超声的多模态放射组学模型对慢性肾脏病纤维化检测的诊断准确性。
Eur Radiol. 2023 Apr;33(4):2386-2398. doi: 10.1007/s00330-022-09268-3. Epub 2022 Dec 1.
8
Quantitative Assessment of Liver Impairment in Chronic Viral Hepatitis with [Tc]Tc-Mebrofenin: A Noninvasive Attempt to Stage Viral Hepatitis-Associated Liver Fibrosis.应用[Tc]Tc-美菲醌定量评估慢性病毒性肝炎肝损害:病毒性肝炎相关肝纤维化分期的无创尝试。
Medicina (Kaunas). 2022 Sep 23;58(10):1333. doi: 10.3390/medicina58101333.
9
Fully Automated and Explainable Liver Segmental Volume Ratio and Spleen Segmentation at CT for Diagnosing Cirrhosis.CT 上用于诊断肝硬化的全自动且可解释的肝脏节段体积比及脾脏分割
Radiol Artif Intell. 2022 Aug 24;4(5):e210268. doi: 10.1148/ryai.210268. eCollection 2022 Sep.
10
Rethinking Liver Fibrosis Staging in Patients with Hepatocellular Carcinoma: New Insights from a Large Two-Center Cohort Study.肝细胞癌患者肝纤维化分期的重新思考:来自一项大型两中心队列研究的新见解
J Hepatocell Carcinoma. 2022 Aug 12;9:751-781. doi: 10.2147/JHC.S372577. eCollection 2022.

本文引用的文献

1
Multidetector Computed Tomography for Retrospective, Noninvasive Staging of Liver Fibrosis.多排螺旋 CT 对肝纤维化的回顾性无创分期。
Gastroenterol Clin North Am. 2018 Sep;47(3):569-584. doi: 10.1016/j.gtc.2018.04.012. Epub 2018 Jul 7.
2
Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus.MDCT 对丙型肝炎病毒患者肝纤维化分期的肝表面结节量化的准确性。
Abdom Radiol (NY). 2018 Nov;43(11):2980-2986. doi: 10.1007/s00261-018-1572-6.
3
CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges.CT纹理分析:定义、应用、生物学关联及挑战
Radiographics. 2017 Sep-Oct;37(5):1483-1503. doi: 10.1148/rg.2017170056.
4
Texture analysis of the liver at MDCT for assessing hepatic fibrosis.多层螺旋CT对肝脏进行纹理分析以评估肝纤维化
Abdom Radiol (NY). 2017 Aug;42(8):2069-2078. doi: 10.1007/s00261-017-1096-5.
5
Technical Failure of MR Elastography Examinations of the Liver: Experience from a Large Single-Center Study.肝脏磁共振弹性成像检查的技术失败:来自一项大型单中心研究的经验
Radiology. 2017 Aug;284(2):401-412. doi: 10.1148/radiol.2016160863. Epub 2017 Jan 3.
6
Global epidemiology and burden of HCV infection and HCV-related disease.全球丙型肝炎病毒感染及相关疾病的流行病学和负担。
Nat Rev Gastroenterol Hepatol. 2017 Feb;14(2):122-132. doi: 10.1038/nrgastro.2016.176. Epub 2016 Dec 7.
7
Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis.多层螺旋CT对肝脾进行容积评估以诊断肝纤维化分期。
Eur Radiol. 2017 Jul;27(7):3060-3068. doi: 10.1007/s00330-016-4648-0. Epub 2016 Nov 17.
8
Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death.肝脏表面结节评分可预测肝硬化失代偿和死亡。
Radiology. 2017 Jun;283(3):711-722. doi: 10.1148/radiol.2016160799. Epub 2016 Nov 3.
9
Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis.多层螺旋CT肝脏表面结节量化作为肝纤维化分期无创生物标志物的准确性
AJR Am J Roentgenol. 2016 Dec;207(6):1194-1199. doi: 10.2214/AJR.16.16514. Epub 2016 Aug 30.
10
Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis.从常规 CT 图像中定量肝脏表面结节作为肝硬化检测和评估的生物标志物。
Radiology. 2016 Sep;280(3):771-81. doi: 10.1148/radiol.2016151542. Epub 2016 Apr 18.

多参数 CT 对丙型肝炎病毒相关肝纤维化的无创分期:与组织病理学纤维化评分的相关性。

Multiparametric CT for Noninvasive Staging of Hepatitis C Virus-Related Liver Fibrosis: Correlation With the Histopathologic Fibrosis Score.

机构信息

1 Department of Radiology, University of Wisconsin School of Medicine & Public Health, E3/311 Clinical Science Center, 600 Highland Ave, Madison, WI 53792-3252.

出版信息

AJR Am J Roentgenol. 2019 Mar;212(3):547-553. doi: 10.2214/AJR.18.20284. Epub 2019 Jan 15.

DOI:10.2214/AJR.18.20284
PMID:30645162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6945751/
Abstract

OBJECTIVE

The objective was to develop a multiparametric CT algorithm to stage liver fibrosis in patients with chronic hepatitis C virus (HCV) infection.

MATERIALS AND METHODS

Abdominal CT and laboratory measures in 469 patients with HCV (340 men and 129 women; mean age, 50.1 years) were compared against the histopathologic Metavir fibrosis reference standard (F0, n = 49 patients; F1, n = 69 patients; F2, n = 102 patients; F3, n = 76 patients; F4, n = 173 patients). From the initial candidate pool, nine CT and two laboratory measures were included in the final assessment (CT-based features: hepatosplenic volumetrics, texture features, liver surface nodularity [LSN] score, and linear CT measurements; laboratory-based measures: Fibrosis-4 [FIB-4] score and aspartate transaminase-to-platelets ratio index [APRI]). Univariate logistic regression and multivariate logistic regression were performed with ROC analysis, proportional odds modeling, and probabilities.

RESULTS

ROC AUC values for the model combining all 11 parameters for discriminating significant fibrosis (≥ F2), advanced fibrosis (≥ F3), and cirrhosis (F4) were 0.928, 0.956, and 0.972, respectively. For all nine CT-based parameters, these values were 0.905, 0.936, and 0.972, respectively. Using more simplified panels of two, three, or four parameters yielded good diagnostic performance; for example, a two-parameter model combining only LSN score with FIB-4 score had ROC AUC values of 0.886, 0.915, and 0.932, for significant fibrosis, advanced fibrosis, and cirrhosis. The LSN score performed best in the univariate analysis.

CONCLUSION

Multiparametric CT assessment of HCV-related liver fibrosis further improves performance over the performance of individual parameters. An abbreviated panel of LSN score and FIB-4 score approached the diagnostic performance of more exhaustive panels. Results of the abbreviated panel compare favorably with elastography, but this approach has the advantage of retrospective assessment using preexisting data without planning.

摘要

目的

本研究旨在开发一种多参数 CT 算法,以对慢性丙型肝炎病毒(HCV)感染患者的肝纤维化进行分期。

材料与方法

对 469 例 HCV 患者(男 340 例,女 129 例;平均年龄 50.1 岁)的腹部 CT 和实验室检查结果与组织学 Metavir 纤维化参考标准(F0 期 49 例,F1 期 69 例,F2 期 102 例,F3 期 76 例,F4 期 173 例)进行比较。在初始候选池中,有 9 项 CT 检查和 2 项实验室检查纳入最终评估(基于 CT 的特征:肝脾容积测量、纹理特征、肝表面结节[LSN]评分和线性 CT 测量;基于实验室的指标:纤维化-4[FIB-4]评分和天冬氨酸转氨酶与血小板比值指数[APRI])。使用 ROC 分析、比例优势模型和概率进行单变量和多变量逻辑回归。

结果

该模型联合所有 11 个参数鉴别显著纤维化(≥F2)、进展性纤维化(≥F3)和肝硬化(F4)的 ROC AUC 值分别为 0.928、0.956 和 0.972。对于所有 9 项基于 CT 的参数,这些值分别为 0.905、0.936 和 0.972。使用更为简化的两、三或四个参数组合也能获得较好的诊断性能;例如,LSN 评分与 FIB-4 评分联合的二参数模型,其鉴别显著纤维化、进展性纤维化和肝硬化的 ROC AUC 值分别为 0.886、0.915 和 0.932。LSN 评分在单变量分析中表现最佳。

结论

多参数 CT 评估 HCV 相关肝纤维化的表现优于单一参数。由 LSN 评分和 FIB-4 评分组成的简化模型,其诊断性能与更全面的模型相当。该简化模型的结果与弹性成像相比具有优势,但该方法具有利用现有数据进行回顾性评估而无需计划的优势。